Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

It’s Flu and Cold Season: How Over-the-Counter Remedies Can Help Relieve Cough and Chest Congestion

YourUpdateTV

As influenza activity begins to increase in October, now is the time to know how to navigate this cold and flu season. Recently, New York Times bestselling author, Dr. Ian Smith teamed with Mucinex and YourUpdateTV on a satellite media tour to discuss how to relieve cold, cough, and chest congestion symptoms. A video accompanying this announcement is available at: https://youtu.be/vfd-KUPmT3U While seasonal influenza viruses are detected year-round, flu viruses are most common during the fall and winter – kicking off in October. So, as we enter another unprecedented cold & flu season, we can still expect to see an increase in cold and flu cases between now and February. That said, according to Dr. Ian Smith, we should still continue to take key preventative measures to avoid catching any of these viruses. This includes wearing a mask in crowded public places, washing your hands often and covering your nose and mouth with a tissue or your elbow when you cough and sneeze to prevent the spread of germs. While there is no cure for the common cold or flu, there are over-the-counter medications that can help when you start to feel those classic cold and flu symptoms coming on. For instance, Mucinex has a line of 12-hour products that provide relief. Mucinex DM not only thins and loosens mucus, but also controls cough, providing relief for both wet and dry coughs, lasting up to 12 hours. And Mucinex 12 HR Extended Release Tablets help thin and loosen mucus to relieve chest congestion, and also provide relief for 12 hours. People must use over-the-counter products as directed. If your cold and flu symptoms persist, you should contact your healthcare professional and get checked out if deemed necessary. Dr. Smith also shared self-care recommendations such as exercising regularly and eating healthy. Activities like walking, strength training and yoga are good for the mind and the body. A diet full of nutritious meals packed with fruits and veggies and lean proteins like chicken or fish is also very important for a strong immune system. For more information on how to take care of yourself this cold and flu season, visit Mucinex.com for more information. About Dr. Dr Ian Smith: Dr. Ian Smith is the author of the #1 New York Times bestselling books, SHRED: THE REVOLUTIONARY DIET, and SUPER SHRED: The Big Results Diet, and BLAST THE SUGAR OUT. Dr. Smith’s highly anticipated newest book, The Clean 20, became an instant New York Times best seller, helping hundreds of thousands of people reduce bad sugars from their diet, lose weight, lower blood sugar levels, and cut the cravings. Dr. Smith was appointed by President Obama to a second term on the prestigious President’s Council on Fitness, Sports, and Nutrition. He is currently the medical contributor and co-host of the nationally syndicated television show The Rachael Ray Show. He is a former co-host of the Emmy award winning syndicated daytime talk show, The Doctors. He also served as the medical/diet expert for six seasons on VH1’s highly-rated Celebrity Fit Club, and is the creator and founder of the national health initiatives The 50 Million Pound Challenge and The Makeover Mile. Dr. Smith is the former medical correspondent for NBC News network and for NewsChannel 4 in New York, where he filed reports for NBC Nightly News and The Today Show as well as WNBC’s various news broadcasts. He has appeared extensively on various broadcasts including The Oprah Winfrey Show, The View, Dr. Oz, Steve Harvey Show, The Talk, Larry King Live, Anderson Cooper 360, CNN, MSNBC and many more. He has written for various publications including Time, Newsweek, Men’s Fitness, and the New York Daily News, and has been featured in several other publications including, People, Redbook, Details Magazine, Essence, Ebony, University of Chicago Medicine on the Midway, Cosmopolitan, and Black Enterprise. About YourUpdateTV: YourUpdateTV is a social media video portal for organizations to share their content. It includes separate channels for Health and Wellness, Lifestyle, Media and Entertainment, Money and Finance, Social Responsibility, Sports and Technology. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

October 12, 2021 11:09 AM Eastern Daylight Time

Video

Kadimastem Holds Successful Preliminary Meeting with the FDA (INTERACT) Regarding IsletRx for the Treatment of Diabetes

Kadimastem

Kadimastem Ltd. (TASE: KDST), a clinical stage cell therapy company developing cell therapy treatments for ALS and diabetes, announced today that the Company held a preliminary meeting with the FDA (INTERACT) on October 7, 2021 regarding IsletRx, the company’s cell therapy product in development for the treatment of diabetes. During the meeting, Kadimastem received a response document from the FDA noting that the company’s clinical development plan for IsletRx was being positively considered. It also included constructive comments and guidelines applicable for the next step pre-IND submission. This interaction is of great importance to Kadimastem’s clinical product development process and is an important milestone for the company. It was Kadimastem’s first meeting with the FDA regarding its diabetes project and the FDA’s first review of IsletRx, which demonstrated positive results in preclinical trials. IsletRx is an expanded population of allogeneic stem cells differentiated into functioning insulin producing pancreatic islet cells. The company then uses a proprietary technology to select the purest performing cells from its population and puts them into a microcapsule that protects the cells from being rejected by the body’s immune system. The implanted cells have shown in preclinical studies to be able to detect the sugar levels in the body and to, produce, and secrete, on demand, the required amounts of insulin and glucagon, just like a healthy pancreas. Kadimastem CEO Asaf Shiloni said, "Thanks to Dr. Kfir Molakandov, the Director of Diabetes at Kadimastem, who presented the IsletRx project in an impressive manner, we received a positive response to the company’s clinical development outline from the FDA's expert team, who we believe were overall very impressed with our technology. The FDA’s expert team provided us with important feedback that we will use to prepare for the next step, our Pre-IND submission for IsletRx. I am convinced that the successful meeting and the relevant feedback will contribute to the continued progress of our product development and if all goes well, ultimately provide a cure for those living with diabetes.” Kadimastem Chief Scientist Professor Michel Revel said, “The INTERACT meeting with the FDA is an important step forward and shows that Kadimastem's development plan for its diabetes treatment product, IsletRx, is in the right direction.” About Kadimastem: Kadimastem is a clinical stage cell therapy company, developing and manufacturing "off-the-shelf", allogeneic, proprietary cell products based on its technology platform for the expansion and differentiation of Human Embryonic Stem Cells (hESCs) into functional cells. AstroRx®, the company's lead product, is an astrocyte cell therapy in clinical development as a treatment for ALS. IsletRx is the company's second product in development. IsletRx is comprised of functional pancreatic islet cells intended to cure patients with insulin dependent diabetes. IsletRx demonstrated safety and efficacy in a proof-of-concept preclinical study. An INTERACT meeting took place with the FDA on October 7, 2021 where the diabetes treatment program was discussed and the company received directions how to prepare its Pre-IND submission. Kadimastem was founded by Professor Michel Revel, CSO of the company and Professor Emeritus of Molecular Genetics at the Weizmann Institute of Science. Professor Revel received the Israel Prize for the invention and development of Rebif®, a multiple sclerosis blockbuster drug sold worldwide. Kadimastem is traded on the Tel Aviv Stock Exchange (TASE: KDST). Forward Looking Statement: This document may include forward-looking information as defined in the Securities Law, 5728 – 1968. Forward-looking information is uncertain and mostly is not under the Company's control and the realization or non-realization of forward-looking information will be affected, among other things, by the risk factors characterizing the Company's activity, as well as developments in the general environment and external factors affecting the Company's activity. The Company's results and achievements in the future may differ materially from any presented herein and the Company makes no undertaking to update or revise such projection or estimate and does not undertake to update this document. This document does not constitute a proposal to purchase the Company's securities or an invitation to receive such offers. Investment in securities in general and in the Company in particular bears risks. One should consider that past performance does not necessarily indicate performance in the future. Contact Details Must Have Communications Marjie Hadad marjie@mhc-pr.com Kadimastem Sarah Herzl +972 73-797-1613 s.herzl@kadimastem.com Company Website https://www.kadimastem.com/

October 12, 2021 09:54 AM Eastern Daylight Time

US Digestive Health Announces Pilot with AI-Enhanced Endoscopy Aid Device, GI Genius

US Digestive Health

US Digestive Health, a management services organization created to expand access to high-quality, value-based gastroenterology care, began a trial with GI Genius, a state-of-the-art AI-enhanced endoscopy aid device for the detection of colorectal lesions during colonoscopy. GI Genius utilizes artificial intelligence to improve detection of colorectal cancer during screening colonoscopy procedures. Medtronic received approval from the FDA in April of this year. US Digestive Health initiated a trial of the new technology in July 2021 and is the first practice in Pennsylvania to offer GI Genius. “We are constantly researching and investing in ways to help our providers detect potentially cancerous lesions,” said Dr. Dale Whitebloom, Chief Medical Officer of US Digestive Health. “We want the very best for our patients and if AI helps us to detect cancerous and precancerous lesions more effectively then we want to explore it thoroughly.” GI Genius is a combination of hardware and software that helps identify regions of interest during the colonoscopy. The device is not intended to replace lab sampling or suggest a course of action to the physician – but it does aid in highlighting areas of concern for providers to address. “US Digestive Health is committed to bringing the latest advances in colorectal cancer screening to our communities,” said Jerry Tillinger, CEO of US Digestive Health. “We are proud to be the first practice in Pennsylvania to deploy this incredible technology for our patients.” With offices throughout Central and Southeastern Pennsylvania, including the Greater Philadelphia region, US Digestive Health works hand-in-hand with gastroenterology partner practices to meet the challenges of a fast-changing healthcare landscape. By providing innovative business management and technology solutions that ease administrative burdens and support their financial success, US Digestive Health allows physicians to stay focused on delivering great patient care. US Digestive Health was formed in 2019 by Amulet Capital Partners, LP (“Amulet”), a healthcare private equity investment firm based in Greenwich, Connecticut, in partnership with member practice partner physicians. For more information, visit https://usdigestivehealth.com/ About US Digestive Health As the leading gastroenterology practice on the East Coast, US Digestive Health is at the forefront of the rapidly advancing science of digestive health, bringing new insight into the care, treatment and prevention of digestive health disorders. For more information, visit https://usdigestivehealth.com. About Amulet Capital Partners, LP Amulet Capital Partners, LP is a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector. Amulet seeks to achieve long-term capital appreciation through privately negotiated investments in companies. Amulet Capital Partners focuses on those segments it believes have the most attractive long-term fundamentals with a target investment size generally between $25 million to $150 million. For additional information, please visit www.amuletcapital.com. Media Contact for Amulet Capital Partners, LP Melissa Sheer Kent Place Communications, LLC 917-690-2199 melissa@kentplacellc.com Contact Details Noah Ramagano nramagano@usdhealth.com Company Website https://usdigestivehealth.com

October 12, 2021 07:56 AM Eastern Daylight Time

MOTIS Brands Acquires Mac’s Custom Tie-Downs

Rotunda Capital Partners LLC

MOTIS Brands (“MOTIS”), a Rotunda Capital Partners portfolio company, has acquired Mac’s Custom Tie-Downs (“Mac’s”), a leading manufacturer of high-quality tie-down systems for trailers and truck beds. For nearly 30 years, Mac’s has been innovating and producing tie-down solutions from their headquarters in Sagle, Idaho. The acquisition of Mac’s adds another premium brand to MOTIS’s portfolio of loading, hauling, automotive, and accessibility brands, and further strengthens its position as a leader in truck and trailer cargo control. “We are excited to add Mac’s line of outstanding products and their talented team to the MOTIS family of brands,” said MOTIS CEO Rich Spratt. “Mac’s adds additional U.S. manufacturing capabilities and another strong brand to our assortment. Our goal remains to assemble the broadest and deepest collection of premium products for loading, hauling, storage and productivity needs, and Mac’s is an ideal addition to our offering.” About MOTIS Brands Headquartered in Germantown, WI, MOTIS Brands proudly designs, develops, and distributes a collection of industry leading loading, hauling, automotive and accessibility brands including Race Ramps®, Silver Spring Mobility®, Heavy Duty Ramps™, Black Widow®, Guardian Industrial Products™, Kill Shot®, Tilt-a-Rack®, Harbor-Mate®, Lucky Dog™, Big Boy®, and Mac’s Custom Tie-Downs. For more information, visit www.motisbrands.com. About Rotunda Capital Partners Rotunda Capital Partners is a private equity firm that invests equity capital in established, lower middle market companies. Rotunda partners with management to build data-driven growth platforms within its targeted sectors, including value-added distribution, asset light logistics and industrial/business services. Founded in 2009, the firm has a long history of helping management teams achieve their goals for growth. The Rotunda team actively provides guidance and draws on deep industry and financial relationships to contribute to the successful execution of Rotunda’s companies’ strategic plans. The firm has offices in Bethesda, MD and Evanston, IL. For more information, visit www.rotundacapital.com. Contact Details Jill Lafferty +1 847-280-1295 jill@rotundacapital.com Company Website https://www.rotundacapital.com

October 12, 2021 07:34 AM Eastern Daylight Time

Harrods enters the limited-edition sneaker market welcoming The Edit LDN

Stockwood Strategy

The UK’s leading online store for limited edition sneakers and high-end streetwear The Edit LDN, today announced the opening of its first ever UK boutique store in Harrods, one of London’s most famous department stores. Harrods visitors will be able to see, experience and buy the latest limited-edition sneakers from The Edit LDN. Already popular with royalty, celebrities and footballers, The Edit LDN is a leading online destination that sells the hottest and hardest to get sneakers and streetwear from brands including Yeezy, Jordan, Off-White and collaborations through to Supreme, among others to a wide community of fashionistas, collectors and investors. Just as premium sites like Farfetch address the fashion world, The Edit LDN showcases the latest sneakers and high-end streetwear. They connect premium resellers with a highly engaged, price agnostic and eager audience. Moses Rashid, Founder and CEO of The Edit LDN commented: “We want to expand and increase accessibility for people who want to own limited edition sneakers around the world. Being the first sneaker reseller in Harrods is a proud and milestone moment for the company and its great to see such a global mega brand engaging with the sneaker market, moreover, that we're the catalyst to make that happen. Harrods offers an amazing customer journey to their global customer base and this aligns completely with our approach, to offer the best in class service. In 18 months, we have expanded our community of buyers from avid sneaker fans to TV and film celebrities as well as professional footballers and royal families around the world. Opening in Harrods is a logical next step as we bring our unique proposition to their customer base”. The Edit LDN has established itself as a trusted source of authenticated and high quality new and pre-loved streetwear and sneakers. Their unabating focus on speed (to deliver purchased goods), customer service engagement and ensuring all goods are authenticated has been testament to the growth of the platform and community. Simon Longland, Head of Menswear at Harrods commented: “Over the past three years, menswear at Harrods has undertaken a huge transformation, that has been visible through our brand curation as well as the physical shop floor. Our goal has been to transform the menswear experience at Harrods and embrace the most important and desirable trends on the market, and the launch of The Edit LDN continues that strategy. Bringing The Edit LDN’s industry expertise to Harrods ensures that our customers have access to the latest and most exclusive styles on the market through a service level which is unmistakably Harrods.” Helen David, Chief Merchant at Kurt Geiger added: “We’ve been at the forefront of embracing the latest trends serving a wide and diverse range of customers. What used to be considered sportswear is now considered luxury, and the shoes that are the most wanted and the hottest tickets are now sneakers. Without this as part of our matrix at Harrods, we wouldn’t have a proper 360 luxury offer. Hosting The Edit LDN at Harrods is testament to our commitment of meeting our customer needs with the market-leader in the premium sneaker business. Our shared objective with The Edit LDN is to ensure that Harrods’ customers have access to the latest and best on the market to meet their lifestyle needs.” Looking ahead, Moses said: “This is a marketplace worth $6b a year globally and will grow 5x by 2030. The demand for sneakers is growing every day and we are at the heart of servicing this trend. It’s been a remarkable 18 months since we launched to now opening in Harrods, the world’s most iconic department store. We are in hyper growth and headed in the right trajectory as we scale the business globally. Our on-going funding round will enable us to move faster and achieve our goals“. About The Edit LDN Founded in 2020, The Edit LDN has quickly become the UK’s leading online consignment store for limited edition sneakers and high end streetwear, both new and pre-loved items. Their innovative platform connects premium resellers to a global audience offering a deluxe experience from discovery, packaging and delivery. Brands include Jordan, Yeezy, Louis Vuitton, Dior, Off-White, Supreme, Fear of God among others. The platform is fast becoming synonymous with speed of service, authenticity, diverse selection of secure payment methods, and first class customer service. The Edit LDN is the leading destination for resellers and their premium sneakers and streetwear. Through partnerships with styling services such as Thread.com and various concierge companies, The Edit LDN has a community of buyers celebrities to professional footballers and royal families around the world. Further information visit: www.theeditldn.com. You are welcome to follow us on LinkedIn, Facebook or Instagram About Harrods Harrods began as a wholesale grocer and tea merchant in east London, first opening its doors in 1834. Since then, it has grown to become the world’s most famous department store, known for its unrivalled range of luxury merchandise. As well as exclusive brands and myriad departments, one of Harrods’ most renowned attributes is its unparalleled service. Harrods continues to be guided by its philosophy of “anything is possible” and, to this day, our customers remain at the heart of everything we do. Harrods.com About Kurt Geiger Kurt Geiger is a premium footwear brand operating across the UK. It first opened its doors on Bond Street in 1963. Kurt Geiger's own brands for women, men and children include Kurt Geiger London, KG, Carvela and Miss KG. Kurt Geiger has operated the Harrods and Selfridges footwear departments for the past 25 years. This unique positioning sets Kurt Geiger apart as a distinctive and unparalleled multi-channel business selling third-party and owned brands through department store concessions. The brand has over 80 stores worldwide, kurtgeiger.com, as well as e-commerce concession sites and wholesale partners. Selling over four million pairs of shoes a year this makes Kurt Geiger the largest luxury footwear retailer in Europe. Contact Details The Edit LDN Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.theeditldn.com/

October 11, 2021 09:00 AM Eastern Daylight Time

Image

Motor vehicle crash victims more likely to suffer harm in the hospital reports Patient Safety Authority

Patient Safety Authority

Patients who have experienced trauma from a motor vehicle crash are more likely to suffer harm when they go to the hospital in Pennsylvania compared to other patients. That’s according to the Patient Safety Authority (PSA) and the first-of-its-kind analysis of safety events in the hospital involving patients admitted following a motor vehicle crash. The report was published in the September 2021 issue of PATIENT SAFETY. Every hour in Pennsylvania, there are about 14 motor vehicle crashes—with one fatality every 8 hours—according to the Pennsylvania Department of Transportation (2019). More than 200 people are injured in crashes every day, many of whom wind up in the hospital. The information, from PSA’s patient safety database, PA-PSRS, is from 2018–2020. “Typically, 3% of reports of patient safety events are classified as serious,” says researcher Elizabeth Kukielka, PharmD, MA, RPh. “However in this study, we found that number more than quadrupled, with more than 13% of reports being classified as serious events. “We must be cautious in drawing conclusions about why, as this could have as much to do with the patient’s condition upon arrival at a hospital as it does with the actions of healthcare providers.” Crash victims who wind up in the emergency room are often unconscious, physically incapacitated or suffering from confusion, impacting their ability to participate in their own care. “That could lead to communication breakdowns,” says Kukielka. In addition to issues with communication, contributing factors to patient harm include lack of policies or awareness of existing policies, and prioritizing the patient’s condition from the crash over underlying health conditions. Other topics in this issue of PATIENT SAFETY include: Elder suicide in skilled nursing facilities – In Pennsylvania, people 65 and older are five times more likely to commit suicide than people under 20. Moving to a nursing home can be an especially difficult, high-risk period, so facilities should do a mental health screening, especially learning about the resident’s pre-admission behavior patterns. Safety trade-offs in home care during COVID-19 - A new study examined home care workers’ experience during COVID-19. Not surprisingly, they often prioritized patient needs over their own, despite the high-risk, low-pay nature of the job. The study reaffirms the need for a focus on improved safety protocols for vulnerable home care patients and workers. The impact of COVID-19 on medical device reporting and investigation – While the impact of COVID-19 on patient care is still unfolding, what about its impact on investigating malfunctioning medical devices? A study found that delays were due to travel bans, limited capabilities (e.g. stay-at-home-orders), device contamination concerns, patients’ reluctance to visit their doctor and cancellations of elective procedures. The potential consequences: a backlog of uninvestigated devices, lost information over time and lack of post market surveillance leading to adverse events that could have otherwise been prevented. PATIENT SAFETY is the peer-reviewed journal of the Patient Safety Authority. A scientific publication, PATIENT SAFETY humanizes patient harm with stories, opinion pieces, and magazine-quality design. It has a readership of more than 45,000 people in 164 countries. About PSA Established under the Medical Care Availability and Reduction of Error (MCARE) Act of 2002, the PSA, an independent state agency, collects and analyzes patient safety data to improve safety outcomes and help prevent patient harm. http://patientsafety.pa.gov/ Contact Details Bev Volpe +1 609-230-4696 bev@madisongall.com Company Website http://patientsafety.pa.gov/

October 08, 2021 10:27 AM Eastern Daylight Time

Image

ThreatModeler Announces Commitment to Global Cybersecurity Advocacy Efforts as a 2021 Cybersecurity Awareness Month Champion

National Cyber Security Alliance

Automated Threat Modeling Leader Becomes Joins Worldwide Initiative to Reinforce the Importance of Proper Cybersecurity Protection Measures for Individuals and Organizations in an Increasingly Connected World ThreatModeler today announced its commitment to Cybersecurity Awareness Month, held annually in October, by signing up as a 2021 Champion and joining a growing global effort to promote the awareness of online safety and privacy. The Cybersecurity Awareness Month Champions Program is a collaborative effort among businesses, government agencies, colleges and universities, associations, nonprofit organizations and individuals committed to the Cybersecurity Awareness Month theme of ‘Do Your Part. #BeCyberSmart.’ “At ThreatModeler, we empower organizations to securely develop their most crucial applications and infrastructure.” said Archie Agarwal, Founder and CEO of ThreatModeler. “In line with Cybersecurity Awareness Month, ThreatModeler is proud to continue our work in championing industry best practices and ensuring organizations have the knowledge and the tools to stay well ahead of major vulnerabilities moving forward.” More than ever before, technology plays a part in almost everything we do. Connected devices have been woven into society as an integral part of how people communicate and access services essential to their wellbeing. Despite these great advances in technology and the conveniences this provides, recent events have shown us how quickly our lives and businesses can be disrupted when cyber criminals and adversaries use technology to do harm. Cybersecurity Awareness Month aims to shed light on these security vulnerabilities, while offering actionable guidance surrounding behaviors anyone can take to protect themselves and their organizations. Everyone has a responsibility to do their part in securing our interconnected world. This year, the Cybersecurity Awareness Month’s main weekly focus areas will revolve around: Understanding and implementing basic cyber hygiene, including the importance of strong passphrases, using multi-factor authentication, performing software updates and backing up data. Recognizing and reporting phishing attempts whether it’s through email, text messages, or chat boxes. Empowering individuals to not only practice safe online behavior, but consider joining the mission of securing our online world by considering a career in cybersecurity! Making cybersecurity a priority in business by making products and processes “secure by design” and considering cybersecurity when purchasing new internet-connected devices. If everyone does their part – implementing stronger security practices, raising community awareness, educating vulnerable audiences or training employees – our interconnected world will be safer and more resilient for everyone. Now in its 18th year, Cybersecurity Awareness Month continues to build momentum and impact with the ultimate goal of providing everyone with the information they need to stay safer and more secure online. ThreatModeler is proud to support this far-reaching online safety awareness and education initiative which is co-led by the National Cyber Security Alliance and the Cybersecurity and Infrastructure Agency (CISA) of the U.S. Department of Homeland Security. For more information about Cybersecurity Awareness Month 2021 and how to participate in a wide variety of activities, visit staysafeonline.org/cybersecurity-awareness-month/. You can also follow and use the official hashtag #BeCyberSmart on social media throughout the month. About ThreatModeler ThreatModeler is an automated platform that provides a sustainable, self-service threat modeling practice for applications and infrastructure that evolves as your infrastructure grows. ThreatModeler encourages collaboration through its simple process flow diagram-based functionality that’s easy to use in the creation of threat models that identify, prioritize and mitigate threats, while communicating them broadly. ThreatModeler integrates with JIRA, Jenkins, and Azure Boards and Pipelines, with bidirectional web services API also unifying stakeholders in collaboration. Teams are empowered to code fearlessly and deliver new products with security built in as early as the design phase, which is based on global security and compliance standards. About Cybersecurity Awareness Month Cybersecurity Awareness Month is designed to engage and educate public- and private-sector partners through events and initiatives with the goal of raising awareness about cybersecurity to increase the resiliency of the nation in the event of a cyber incident. Since the Presidential proclamation establishing Cybersecurity Awareness Month in 2004, the initiative has been formally recognized by Congress, federal, state and local governments and leaders from industry and academia. This united effort is necessary to maintain a cyberspace that is safer and more resilient and remains a source of tremendous opportunity and growth for years to come. For more information, visit staysafeonline.org/cybersecurity-awareness-month/ About National Cyber Security Alliance The National Cyber Security Alliance is a nonprofit alliance on a mission to create a more secure connected world. We enable powerful, public-private partnerships in our mission to educate and inspire individuals to protect themselves, their families and their organizations for the collective good. Our primary partners are the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency (CISA) and our Board of Directors, which includes representatives from ADP; AIG; Bank of America; Cofense; Discover; Eli Lilly and Company; ESET North America; Facebook; KnowBe4; La-Z-Boy; Lenovo; Marriott International; Mastercard; Microsoft; Mimecast; NortonLifeLock; Paubox; Proofpoint; Raytheon Intelligence & Space; Terranova Security; US Bank; VISA; Wells Fargo. The National Cyber Security Alliance’s core efforts include Cybersecurity Awareness Month (October); Data Privacy Day (Jan. 28); Identity Management Day; and CyberSecure My Business™. For more information on the National Cyber Security Alliance, please visit https://staysafeonline.org. Contact Details Mike Stolyar threatmodeler@luminapr.com Company Website https://www.threatmodeler.com

October 07, 2021 09:00 AM Eastern Daylight Time

American Kidney Fund Receives New Support for Educational Know Your Kidneys™ Campaign

American Kidney Fund

The American Kidney Fund (AKF) today recognizes new support from Otsuka America Pharmaceutical, Inc. and Boehringer Ingelheim/Lilly for AKF’s ongoing nationwide education campaign, Know Your Kidneys™, aimed at empowering individuals to fulfill life’s possibilities by preventing or slowing the progression of chronic kidney disease (CKD). This support will make it possible for AKF to continue to reach those most at-risk for CKD with important messages about the need to know your kidneys. One in seven Americans has kidney disease, yet the vast majority with early CKD—96%—are unaware of it because it typically has no symptoms until the late stages when the kidneys are already badly damaged. The Know Your Kidneys campaign encourages Americans to better understand the central role their kidneys play in their overall health and to take action to ensure early diagnosis and proper management of CKD, along with its main precursors high blood pressure and diabetes, to help prevent or slow the progression. “We are very appreciative that our new partners understand the urgency behind our efforts to improve awareness of kidney health and increase access to educational tools that will help Americans receive an earlier diagnosis of kidney disease and even prevent it altogether,” said LaVarne A. Burton, AKF President and CEO. “We’ve seen great engagement so far with Know Your Kidneys and hope to reach even more at-risk individuals, particularly people of color, who are more likely to progress to kidney failure due to persisting disparities in care that prevent them from receiving an early diagnosis.” The campaign has a positive message: by knowing the state of your kidneys, you can ultimately know a longer, healthier life. It features educational content and downloadable discussion guides to encourage patients to start critical conversations with their health care teams to protect their kidneys before and after a kidney disease diagnosis. “More than a third of U.S. patients who receive a kidney failure diagnosis have little or no nephrology care prior to reaching the point of needing dialysis or a kidney transplant to survive,” said Burton. “By continuing Know Your Kidneys, we hope more Americans can be aware of their kidney function and access early intervention to help slow or stop the progression of kidney disease to kidney failure.” ### About the American Kidney Fund The American Kidney Fund (AKF) fights kidney disease on all fronts as the nation’s leading kidney nonprofit. AKF works on behalf of the 37 million Americans living with kidney disease, and the millions more at risk, with an unmatched scope of programs that support people wherever they are in their fight against kidney disease—from prevention through transplant. With programs that address early detection, disease management, financial assistance, clinical research, innovation and advocacy, no kidney organization impacts more lives than AKF. AKF is one of the nation’s top-rated nonprofits, investing 97 cents of every donated dollar in programs, and holds the highest 4-Star rating from Charity Navigator and the Platinum Seal of Transparency from GuideStar. For more information, please visit KidneyFund.org, or connect with us on Facebook, Twitter, Instagram and LinkedIn. Contact Details Stefanie Tuck 202-470-1797 +1 978-390-1394 11921 Rockville Pike Suite 300 Rockville, MD 20852 AKF@jpa.com Company Website https://www.kidneyfund.org/

October 07, 2021 09:00 AM Eastern Daylight Time

News Release

Creating Buzz PR Announces ‘Be Your Own Publicist‘ Class For Entrepreneurs & Small Business Owners

Creating Buzz PR

Creating Buzz PR, one of California and Arizona’s most creative and respected public relations firms, will offer publicity classes for small business owners that typically could not afford the prices of a respected PR firm. Ellie Lowney, founder of Creating Buzz PR, has catapulted companies such as Superstition Meadery and Personality Hotels from small start ups to thriving mid size business’s through her creative campaigns. Called ‘Catapult Your Brand With Publicity’, this class will teach entrepreneurs all they need to know to get coverage in respected media outlets such as USA Today, Entrepreneur.com, CNN, Forbes, Local and real (unpaid) TV coverage, local and real print and digital News outlets, INC.com, and much more. “I want to help even the playing field for small business owners” states Ellie. “They are the backbone of America and so many have great ideas and intentions but fail in the first year or two, which is sad.” According to statistics published in 2019 by the Small Business Administration (SBA), about twenty percent of business startups fail in the first year. About half succumb to business failure within five years. By year ten, only about 33% survive. “I know one of the main reasons entrepreneurs fail is because they don’t put enough time, energy, and money into promoting the business”, states Ellie. “I have seen it with friends and potential clients. There is often an attitude of “if I build it - they will come,” so they put tons of money into interior design, or a quality product, and website, but then don’t have enough money left for marketing.” Quality PR firms, including Creating Buzz PR, charge $150.00 to $500.00 and up - per hour, with a minimum of $3000.00 per month, and many small business owners can not afford that. “To hire a good PR pro is expensive because it is time consuming to do it right and requires a talented person who can wear many hats including research to create the right campaign and brand, writing great stories, pitching the media (sales), being a sleuth to find those perfect journalists, etc”. “It is not for the faint of heart. Companies should know it is like hiring your content creation team, sales team, business coach, idea person, project manager, connector, and more in one or two people.” Being a small business owner herself and having many friends that are entrepreneurs, Ellie saw the need for classes for startups, that have more time than money, to put into promotion. “Entrepreneurs should always be thinking of promoting and how they can gain credibility and interest from their target market before they even start the business” states Ellie. The first three classes of the six week course will cover how to write a compelling story and make it newsworthy, finding the right journalists and media outlets, writing press releases, media alerts, and pitches, and - most importantly - how to pitch the media. The second half of the course will cover newswires, such as News Direct and Cision, plus social media, business building events, media stunts, and more. The classes will be interactive through Zoom and will be kept to a small group, so all attendees can ask questions and get personalized help. Additionally there are specific class’s for health and aesthetic practice publicity and hospitality and restaurant publicity. “I so believe in publicity in respected media outlets and what it can do for a brand,” states Ellie. I have seen it happen with my clients, where they see their sales triple, then skyrocket, in a few short months from great press, or see their business launched from just one event.” About Creating Buzz PR and Ellie Lowney Ellie is a writer and senior communications specialist with twenty years experience in PR and marketing. Ellie has led campaigns for companies and brands such as The Fairmont Hotel, Core Institute, Superstition Meadery, WorldWildlife Fund, Pacific Autism Centers, Personality Hotels, Biogenesis Nutraceuticals, and many more. She started in PR in San Francisco and started Creating Buzz PR in 2017. Creating Buzz PR, 4232 N 32nd Street, Phoenix, AZ., 85018 www.creatingbuzzpr.com https://creatingbuzzpr.com/catapult-your-brand-2/ About Creating Buzz PR and Ellie Lowney Ellie is a writer and senior communications specialist with twenty years experience in PR and marketing. Ellie has led campaigns for companies and brands such as The Fairmont Hotel, Core Institute, Superstition Meadery, WorldWildlife Fund, Pacific Autism Centers, Personality Hotels, Biogenesis Nutraceuticals, and many more. She started in PR in San Francisco and started Creating Buzz PR in 2017. Creating Buzz PR, 4232 N 32nd Street, Phoenix, AZ., 85018 https://www.creatingbuzzpr.com https://creatingbuzzpr.com/catapult-your-brand-2/ Contact Details Creating Buzz PR Ellie +1 415-948-5275 Elizabeth@CreatingBuzzPR.com Company Website https://www.creatingbuzzpr.com

October 07, 2021 06:00 AM Eastern Daylight Time

1 ... 256 257 258 259 260 ... 309